Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 9/20 | 0.34 |
| ▸ | CNR1 | P21554 | 7/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | PPARD | Q03181 | 1/20 | 0.31 |
| ▸ | PPARA | Q07869 | 1/20 | 0.31 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3227143 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1TRPA1TRPV1 | |
| SCHEMBL3784577 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1TRPA1TRPV1 | |
| SCHEMBL3791597 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1TRPA1TRPV1 | |
| SCHEMBL14219773 | 1.00 | — | — | |
| SCHEMBL418718 | 1.00 | — | — | |
| SCHEMBL3784576 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1TRPA1TRPV1 | |
| SCHEMBL330063 | 1.00 | — | — | |
| SCHEMBL330064 | 1.00 | — | — | |
| SCHEMBL3230987 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CNR2CNR1TRPA1TRPV1 | |
| SCHEMBL27447177 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100068480-A1 | Negative-working photosensitive resin composition and photosensitive resin plate using the same | CITICORP NORTH AMERICA, INC., AS AGENT | 2010-03-18 | — | — | US | disclosed |
| EP-1501774-B9 | POLYUNSATURATED LINEAR ALDEHYDES AND THEIR DERIVATIVES WITH ANTI-RADICAL ACTIVITY | GIULIANI SPA (IT) | 2010-02-24 | — | — | EP | disclosed |
| EP-1501774-B1 | POLYUNSATURATED LINEAR ALDEHYDES AND THEIR DERIVATIVES WITH ANTI-RADICAL ACTIVITY | GIULIANI SPA (IT) | 2009-08-12 | — | — | EP | disclosed |
| US-20090068413-A1 | Negative-working photosensitive resin composition and photosensitive resin plate using the same | TAKANASHI HIROSHI | 2009-03-12 | — | — | US | disclosed |
| US-20060275702-A1 | Negative-working photosensitive resin composition and photosensitive resin plate using the same | TAKANASHI HIROSHI | 2006-12-07 | — | — | US | disclosed |
| US-20060057495-A1 | Negative-working photosensitive resin composition and photosensitive resin plate using the same | TAKANASHI HIROSHI | 2006-03-16 | — | — | US | disclosed |
| US-20050175555-A1 | Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity | UNIVERSITA' DELGI STUDI DI MILANO (IT) | 2005-08-11 | — | — | US | disclosed |
| US-20010019811-A1 | Negative-working photosensitive resin composition and photosensitive resin plate using the same | TAKANASHI HIROSHI (JP) | 2001-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050175555-A1 | Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity | ALOX5, PRDX5, ALOX15 | ALDH1A1 113/4885CNR2 3000/4885CNR1 3178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.